(Q41535020)

English

High doses of diazepam improve neuroleptic-resistant chronic schizophrenic patients

scientific article published on January 1983

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

High doses of diazepam improve neuroleptic-resistant chronic schizophrenic patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

0 references

0 references

author name string

J N Nestoros

1

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

N P Nair

2

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

J R Pulman

3

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

G Schwartz

4

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

D Bloom

5

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

publication date

1 January 1983

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

81

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

42-47

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

https://scigraph.springernature.com/pub.10.1007/bf00439272

0 references

Catecholamines in the brain as mediators of amphetamine psychosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/6138791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence for involvement of dopamine in the action of diazepam: potentiation of haloperidol and chlorpromazine action in the brain.

1 reference

https://pubmed.ncbi.nlm.nih.gov/6138791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospects for research on schizophrenia. An hypotheses suggesting that there is a defect in the GABA system in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/6138791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular Mechanisms in the Receptor Action of Benzodiazepines

1 reference

https://pubmed.ncbi.nlm.nih.gov/6138791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased antistereotypic effect of neuroleptics after additional treatment with a benzodiazepine, a GABA agonist or an anticholinergic compound

1 reference

https://pubmed.ncbi.nlm.nih.gov/6138791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benzodiazepines in Schizophrenia: A Need for Reassessment

1 reference

https://pubmed.ncbi.nlm.nih.gov/6138791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The psychotic inpatient profile: A nurse's observation scale

1 reference

https://pubmed.ncbi.nlm.nih.gov/6138791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The dopamine hypothesis of schizophrenia: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/6138791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of gamma-hydroxybutyric acid, baclofen, aminooxyacetic acid, and apomorphine on dopamine turnover in corpus striatum and limbic system

1 reference

https://pubmed.ncbi.nlm.nih.gov/6138791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sodium valproate in schizophrenia: some biochemical correlates

1 reference

https://pubmed.ncbi.nlm.nih.gov/6138791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gabaergic processes involved in the control of dopamine release from nigrostriatal dopaminergic neurons in the cat

1 reference

https://pubmed.ncbi.nlm.nih.gov/6138791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

gamma-Aminobutyric acid (Gaba) and the dopamine hypothesis of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/6138791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipsychotic drugs, neurotransmitters, and schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/6138791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Letter: Baclofen in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/6138791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Muscimol: GABA agonist therapy in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/6138791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Letter: Bacloffen in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/6138791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diazepam in schizophrenia: a preliminary double-blind trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/6138791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High dose diazepam in schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/6138791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Actions of GABAergic agents on dopamine metabolism in the nigrostriatal pathway of the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/6138791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00439272

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41535020&oldid=1924105242"